HI 2026 Abstract Submission
  • ABSTRACT SUBMISSION FORM

  • Topics in Hyperinsulinism

    October 1 - 3, 2026
  • Abstract Submission Deadline: May 22, 2026 (11:59 PM EST)

    Notification of Acceptance: July 15, 2026 (11:59 PM EST)

     

    Abstract Submission Guidelines

    Abstracts may only be submitted electronically.

    Abstract must total no more than 500 words (not including title, authors and institutions).

    All abstracts must contain the following four sections: Background/Objectives, Methods, Results, Conclusion.

    The following types of abstracts will be considered:

    • Case Reports
    • Clinical Research
    • Basic Science Research
    • Translational Research

     

    While images cannot be accommodated for the abstract submission and evaluation process, they are an anticipated part of each prepared poster or oral presentation.

    Selected abstracts will be invited for oral or poster presentations.

    If your abstract has been previously published in the proceedings of scientific meetings, but is not yet a published manuscript, it will be considered for presentation.

    Acceptance of an abstract does not include course registration fees, transportation or lodging.

  • Format: (000) 000-0000.
  • Rows
  • 0/500
  • Should be Empty: